SLC2A1 and B-cell non-Hodgkin lymphoma: Moreover, the activation of the NF-κB signaling pathway increased glucose uptake by inducing the plasma membrane localization of GLUT1, blocking apoptosis, and promoting B-cell lymphoma growth [37].